Mercer Global Advisors
RYTM icon

Mercer Global Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

Mercer Global Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86K Buy
+775
New +$70.1K ﹤0.01% 3944

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Mercer Global Advisors's RYTM Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 775 shares worth $86K. The stake represents ﹤0.01% of the portfolio and ranks #3944 among its holdings.

280 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Mercer Global Advisors held 775 shares of Rhythm Pharmaceuticals worth $86K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3944 holding.
  • 280 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.